Pictet Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Hold
5,266
– – ﹤0.01% 1702
2026
Q1
$523K Buy
5,266
+408
+8% +$53.2K ﹤0.01% 1433
2025
Q4
$591K Buy
4,858
+382
+9% +$47.9K ﹤0.01% 1355
2025
Q3
$502K Hold
4,476
– – ﹤0.01% 1380
2025
Q2
$600K Buy
4,476
+42
+0.9% +$4.61K ﹤0.01% 1275
2025
Q1
$298K Hold
4,434
– – ﹤0.01% 1621
2024
Q4
$276K Sell
4,434
-274
-6% -$25.5K ﹤0.01% 1688
2024
Q3
$740K Buy
4,708
+562
+14% +$86.6K ﹤0.01% 1178
2024
Q2
$624K Hold
4,146
– – ﹤0.01% 1182
2024
Q1
$307K Hold
4,146
– – ﹤0.01% 1532
2023
Q4
$327K Hold
4,146
– – ﹤0.01% 1493
2023
Q3
$227K Buy
+4,146
New +$298K ﹤0.01% 1627

Other funds holding TMDX

Pictet Asset Management's TMDX Position: Q2 2026 in Review

Pictet Asset Management held its Transmedics (TMDX) position steady in Q2 2026 at 5,266 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

Pictet Asset Management first reported a position in TMDX in Q3 2023 and has held it in 12 quarters since. The position peaked at $740K in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Pictet Asset Management held 5,266 shares of Transmedics worth $350K as of Q2 2026.
  • Pictet Asset Management left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1702 holding.
  • Pictet Asset Management first reported a position in Transmedics in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Transmedics position peaked at $740K in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.